Literature DB >> 15062632

Executive dysfunction in attention-deficit/hyperactivity disorder: cognitive and neuroimaging findings.

Robert M Roth1, Andrew J Saykin.   

Abstract

Attention-deficit/hyperactivity disorder has been associated with a prominent disturbance of executive functions. There is no pathognomic neuropsychological profile for the disorder, however. Nonetheless, results of neuropsychological testing, in concert with other clinical information,provide a more comprehensive and detailed picture of the individual patient's cognitive and emotional strengths and weaknesses than a psychiatric diagnostic interview alone. This approach to the evaluation of ADHD therefore can provide a strong objective basis from which to make patient-specific recommendations for compensatory strategies and treatment. It should be noted, however, that although executive dysfunction in the form of impaired response inhibition remains the most prominent cognitive theory of ADHD, other theories have been put forth that also deserve further investigation. These include a disturbance in delay aversion (referring to intolerance for waiting) and impaired temporal processing, among others [79]. The neural substrates of executive dysfunction in ADHD have begun to be revealed by a growing body of structural and functional neuroimaging research. Although still in its infancy, neuroimaging of ADHD is pointing toward disruption of FSTC circuitry and the cerebellum as being central to the cognitive and motor abnormalities seen in the disorder. Further research using cognitive tasks assessing executive functions in combination with functional imaging techniques will provide further insight into the etiology of the disorder. It is expected that advances in structural and functional neuroimaging will yield valuable information that will facilitate the differential diagnosis of ADHD. Evidence cited suggests that psychostimulant medication can improve executive functions and their underlying FSTC circuitry. Furthermore, a recent study of adults with ADHD found significant improvements in organization skills and other symptoms of ADHD following cognitive remediation targeting several executive and emotional aspects of the disorder [80]. Additional studies investigating the effects of treatment on executive dysfunction and brain integrity in ADHD will be necessary to determine the degree to which the structural and functional brain abnormalities observed are mutable. Finally, because the myriad cognitive, behavioral and emotional symptoms in ADHD likely reflect the interplay of multiple cognitive and psychosocial factors, development of treatments for ADHD likely will require a multi-modal approach.

Entities:  

Mesh:

Year:  2004        PMID: 15062632     DOI: 10.1016/S0193-953X(03)00112-6

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  18 in total

Review 1.  The neural circuitry of reward and its relevance to psychiatric disorders.

Authors:  David T Chau; Robert M Roth; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

2.  Different neural patterns are associated with trials preceding inhibitory errors in children with and without attention-deficit/hyperactivity disorder.

Authors:  Simona Spinelli; Suresh Joel; Tess E Nelson; Roma A Vasa; James J Pekar; Stewart H Mostofsky
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-06-11       Impact factor: 8.829

Review 3.  [Functional imaging of neurocognitive dysfunction in attention deficit hyperactivity disorder].

Authors:  I Wolf; H Tost; M Ruf; M H Schmidt; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

4.  Transcranial Doppler sonography reveals sustained attention deficits in young adults diagnosed with ADHD.

Authors:  Tyler H Shaw; Timothy W Curby; Kelly Satterfield; Samuel S Monfort; Raul Ramirez
Journal:  Exp Brain Res       Date:  2018-11-22       Impact factor: 1.972

5.  Aversion-related circuitry in the cerebellum: responses to noxious heat and unpleasant images.

Authors:  Eric A Moulton; Igor Elman; Gautam Pendse; Jeremy Schmahmann; Lino Becerra; David Borsook
Journal:  J Neurosci       Date:  2011-03-09       Impact factor: 6.167

6.  Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.

Authors:  Daniel F Connor; Robert L Findling; Scott H Kollins; Floyd Sallee; Frank A López; Andrew Lyne; Gerald Tremblay
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

7.  Mindfulness and attention deficit hyperactivity disorder.

Authors:  Susan L Smalley; Sandra K Loo; T Sigi Hale; Anshu Shrestha; James McGough; Lisa Flook; Steven Reise
Journal:  J Clin Psychol       Date:  2009-10

Review 8.  Attention-deficit hyperactivity disorder in girls: epidemiology and management.

Authors:  Jud Staller; Stephen V Faraone
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

9.  Neonatal dopamine depletion induces changes in morphogenesis and gene expression in the developing cortex.

Authors:  Irina N Krasnova; Elizabeth S Betts; Abiola Dada; Akilah Jefferson; Bruce Ladenheim; Kevin G Becker; Jean Lud Cadet; Christine F Hohmann
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

10.  How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample.

Authors:  István Bitter; Viktoria Simon; Sára Bálint; Agnes Mészáros; Pál Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-10-06       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.